Teva Unveils New Spring 2022 Collection
Teva settles with Rhode Island on opioid-related claims
New York jury holds drug firm Teva liable in opioid crisis
TEVA PHARMACEUTICALS USA, INC: Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States | American Pharmacy News
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis
N.Y. jury holds drugmaker Teva liable in opioid crisis | The Sumter Item
Teva's AJOVY® Receives EU Approval Offering Patients the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Prophylaxis of Migraine in Adults | Nasdaq
Teva Unveils New Spring 2022 Collection
News & Media
News and Media | Teva Pharmaceuticals
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Insilico collaborates with Teva on AI system | EurekAlert!
Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the Non-Insured Health Benefits Program for Patients prescribed AJOVY® (fremanezumab) for the Preventive Treatment of Migraine in
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceuticals (@TevaUSA) / Twitter
Top Factors Driving the Injectable Drug Delivery Formulation Market| A comprehensive study on Key Players- Gerresheimer, Pfizer, Teva Pharmaceutical Industries « MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Price, Quote & News | Stock Analysis
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals (@TevaUSA) / Twitter
$225 Million Settlement Reached With Teva Pharmaceutical Industries Is Fourth Opioid Settlement For Texas - Ksst Radio
